A 52% discontinuation rate (19% due to infections) of mTOR inhibitors in combination or without calcineurin inhibitors was published in 147 patients in a single center retrospective analysis without reporting details in the CNI-free subgroup [15]. The gene discussed is MTOR; the disease is infection.